A G-quadruplex-binding compound showing anti-tumour activity in an in vivo model for pancreatic cancer

Logo poskytovatele
Logo poskytovatele

Varování

Publikace nespadá pod Ekonomicko-správní fakultu, ale pod Středoevropský technologický institut. Oficiální stránka publikace je na webu muni.cz.
Autoři

OHNMACHT Stephan A. MARCHETTI Chiara GUNARATNAM Mekala BESSER Rachael J. HAIDER Shozeb M. DI VITA Gloria LOWE Helen L. MELLINAS-GOMEZ Maria DIOCOU Seckou ROBSON Mathew ŠPONER Jiří ISLAM Barira PEDLEY R. Barbara HARTLEY John A. NEIDLE Stephen

Rok publikování 2015
Druh Článek v odborném periodiku
Časopis / Zdroj Scientific Reports
Fakulta / Pracoviště MU

Středoevropský technologický institut

Citace
www http://www.nature.com/srep/2015/150616/srep11385/pdf/srep11385.pdf
Doi http://dx.doi.org/10.1038/srep11385
Obor Biofyzika
Klíčová slova NAPHTHALENE DIIMIDE LIGANDS; AMBER FORCE-FIELD; DNA G-QUADRUPLEX; MOLECULAR-DYNAMICS; NUCLEIC-ACIDS; TUMOR-CELLS; BCL-2 EXPRESSION; PROMOTER REGION; HUMAN GENOME; GEMCITABINE
Přiložené soubory
Popis We report here that a tetra-substituted naphthalene-diimide derivative (MM41) has significant in vivo anti-tumour activity against the MIA PaCa-2 pancreatic cancer xenograft model. IV administration with a twice-weekly 15 mg/kg dose produces ca 80% tumour growth decrease in a group of tumourbearing animals. Two animals survived tumour-free after 279 days. High levels of MM41 are rapidly transported into cell nuclei and were found to accumulate in the tumour. MM41 is a quadruplexinteractive compound which binds strongly to the quadruplexes encoded in the promoter sequences of the BCL-2 and k-RAS genes, both of which are dis-regulated in many human pancreatic cancers. Levels of BCL-2 were reduced by ca 40% in tumours from MM41-treated animals relative to controls, consistent with BCL-2 being a target for MM41. Molecular modelling suggests that MM41 binds to a BCL-2 quadruplex in a manner resembling that previously observed in co-crystal structures with human telomeric quadruplexes. This supports the concept that MM41 (and by implication other quadruplex-targeting small molecules) can bind to quadruplex-forming promoter regions in a number of genes and down-regulate their transcription. We suggest that quadruplexes within those master genes that are up-regulated drivers for particular cancers, may be selective targets for compounds such as MM41.
Související projekty:

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.